Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 juin 2008 09h03 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At Upcoming Conferences

CAMBRIDGE, Mass., June 6, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
31 mai 2008 09h19 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Clinical Data Confirming Activity and Safety of IPI-504, a Novel Hsp90 Inhibitor, in Patients With Refractory GIST

Disease Control Rate and Partial Response Further Validate Potential for Anti-Chaperone Therapy in GIST Phase 3 Registration Trial of Potential First-in-Class Hsp90...
16 mai 2008 08h27 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Oral Presentation of Results From Clinical Trial of IPI-504 in Patients With GIST At ASCO Annual Meeting

CAMBRIDGE, Mass., May 16, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that updated results from...
05 mai 2008 08h23 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results

CAMBRIDGE, Mass., May 5, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided a research and development...
28 avr. 2008 12h34 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results

CAMBRIDGE, Mass., April 28, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
25 avr. 2008 09h38 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At Morgan Stanley Global Healthcare Unplugged Conference

CAMBRIDGE, Mass., April 25, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven. H....
15 avr. 2008 17h42 HE | Source: Infinity Pharmaceuticals, Inc.

Infinity's Hedgehog Antagonist Delays Tumor Growth Following Chemotherapy in Preclinical Model of Small Cell Lung Cancer; Data Presented At AACR

CAMBRIDGE, Mass., April 15, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that preclinical data from a model of small cell lung cancer (SCLC) show that...
15 avr. 2008 17h01 HE | Source: Infinity Pharmaceuticals, Inc.

Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented by Infinity and MedImmune At AACR

SAN DIEGO, April 15, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune today announced that preclinical studies evaluating lead drug candidate retaspimycin...
13 avr. 2008 17h30 HE | Source: Infinity Pharmaceuticals, Inc.

New Preclinical Data Show Significant Anti-Tumor Activity Associated With Infinity's Hedgehog Antagonist IPI-926

SAN DIEGO, Calif. and CAMBRIDGE, Mass., April 13, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that preclinical studies evaluating IPI-926, Infinity's novel...
07 avr. 2008 08h46 HE | Source: Infinity Pharmaceuticals, Inc.

New Data On Infinity's Lead Anti-Cancer Candidates to be Presented At AACR

CAMBRIDGE, Mass., April 7, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that new data from...

Page précédente